-
July 13: The Week in Cancer NewsAn opinion piece discusses how the stigma surrounding opioids affects cancer patients, and a study provides data on treating melanoma patients with brain metastases.
by Kate Yandell
-
July 6: The Week in Cancer NewsStudies explore what type of cervical cancer screening is most effective and whether patients with autoimmune diseases can take immunotherapy.
by Kate Yandell
-
June 29: The Week in Cancer NewsStudies explore occupational hazards that could increase cancer risk, and the U.S. Food and Drug Administration approves a new combination therapy for melanoma.
by Kate Yandell
-
June 22: The Week in Cancer NewsExperts debate direct-to-consumer genetic testing and studies shed light on breast reconstruction complications.
by Kate Yandell
-
AACR Annual Meeting 2018A roundup of news from the American Association for Cancer Research Annual Meeting 2018.
-
Making Sense of Cancer ProgressCancer Today editor Kevin McLaughlin contemplates what it means to report on cancer research advances when so many continue to die of the disease.
by Kevin McLaughlin
-
A Book Club for Cancer Survivors and CaregiversShare your experiences as we discuss “A Cure Within” in a Cancer Today Facebook group.
by Marci A. Landsmann
-
Welcome to Our New WebsiteAn updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
-
Integrative Strategies for Facing Cancer
Brain tumor survivor uses her experiences to help others.
by Jeannine Walston
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
